SCHEMBL8716377

SCHEMBL8716377

NC(=O)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)NCC(=O)NCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.43
GSTK1 Q9Y2Q3 1/20 0.43
GLO1 Q04760 2/20 0.38
ECE1 P42892 4/20 0.36
CTSD P07339 1/20 0.34
BACE1 P56817 1/20 0.34
PDCD1LG2 Q9BQ51 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
MMP8 P22894 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
OPRD1 P41143 2/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10622634 1.00 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1CTSD
SCHEMBL6831118 1.00 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1CTSD
SCHEMBL4260374 0.99 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1CTSD
SCHEMBL8045766 0.99 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1CTSD
SCHEMBL1472487 0.99 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1CTSD
SCHEMBL9225749 0.97 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1CTSD
SCHEMBL8135287 0.96 PTGS1 (0.45) PTGS1GSTK1GLO1ECE1OPRD1
SCHEMBL8431345 0.96 PTGS1 (0.45) PTGS1GSTK1GLO1ECE1OPRD1
SCHEMBL9067746 0.94 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1OPRD1
SCHEMBL1409212 0.94 PTGS1 (0.46) PTGS1GSTK1GLO1ECE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160289697-A1 AP2 DOMAIN TRANSCRIPTION FACTOR ODP2 (OVULE DEVELOPMENT PROTEIN 2) AND METHODS OF USE PIONEER HI BRED INT (US) 2016-10-06 US disclosed
CN-101228279-A Yield increase in plants overexpressing the MTP genes BASF PLANT SCIENCE GMBH (DE) 2008-07-23 CN disclosed
CN-1194003-A Haloperoxidases from curvularia verruculosa and nucleic acids encoding same NOVO NORDISK AS (DK) 1998-09-23 CN disclosed
EP-0843729-A1 HALOPEROXIDASES FROM CURVULARIA VERRUCULOSA AND NUCLEIC ACIDS ENCODING SAME NOVO NORDISK A/S (DK) 1998-05-27 EP disclosed
WO-1997004102-A1 HALOPEROXIDASES FROM CURVULARIA VERRUCULOSA AND NUCLEIC ACIDS ENCODING SAME NOVO NORDISK A/S (DK) 1997-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160289697-A1 AP2 DOMAIN TRANSCRIPTION FACTOR ODP2 (OVULE DEVELOPMENT PROTEIN 2) AND METHODS OF USE OSBP2, OSBP, OSBPL3 PTGS1 2332/4885GSTK1 2468/4885GLO1 4008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.